Skip to main content
Journal of Maxillofacial & Oral Surgery logoLink to Journal of Maxillofacial & Oral Surgery
. 2020 May 6;20(2):310–318. doi: 10.1007/s12663-020-01380-5

Meta-Analysis to Evaluate the Efficacy of Sternocleidomastoid Muscle Flap as a Reconstruction Modality in Prevention of Frey’s Syndrome Following Parotidectomy

Anuj Jain 1,, Anshul Rai 2
PMCID: PMC8041995  PMID: 33927502

Abstract

Background

One of the commonest complications following parotidectomy is Frey’s syndrome (FS). The use of sternocleidomastoid muscle (SCM) flap to prevent FS is controversial. Hence, this study has been designed to compare the effect of SCM flap with no reconstruction in prevention of FS following parotidectomy.

Methodology

An exhaustive literature search was conducted in July 2019. Studies focusing on sternocleidomastoid flap following parotidectomy were included in the meta-analysis. A random effects model was used to generate pooled estimates. Odds ratio with a 95% confidence interval was calculated for subjective symptoms and objective test.

Results

A total of 125 studies were identified, out of which 17 studies were recruited in the meta-analysis. Sixteen studies were analyzed for the subjective symptoms, and ten were analyzed for the objective signs. There was no statistically significant difference in the occurrence of FS with the use of SCM flap on objective analysis. However, the subjective analysis showed a statistically significant reduction in FS following reconstruction with SCM flap after parotidectomy.

Conclusion

The present meta-analysis suggests that the use of SCM flap following parotidectomy has no effect in reducing the incidence of Frey’s syndrome.

Keywords: Parotidectomy, Frey’s syndrome, Sternocleidomastoid muscle flap

Introduction

Parotid gland is affected by majority of benign and malignant salivary gland tumors. The surgical techniques for management of such pathologies have been evolved with the course of time, and today several techniques have been advocated. However, parotidectomy, either superficial or total depending upon the extent of the tumor, is considered to be the standard treatment. Parotidectomy has a low recurrence rate but it leads to a few postoperative complications which include temporary or permanent injury to facial nerve, loss of ear lobule sensation, cosmetic deformity and Frey's syndrome (FS). These complications significantly affect the quality of life of the patients.

FS is a potential ramification of parotidectomy with a varying incidence of 6% to 96% [1]. Frey in 1923, first identified the notability of the auriculotemporal nerve in the pathogenesis of this condition [2]. This syndrome is a classic triad consisting gustatory sweating, warming and flushing over the preauricular and temporal areas. Its presence may cause social embarrassment and isolation. Numerous medicinal and surgical treatments have been tried, with varying degrees of success. Application of antiperspirant and anticholinergic agents over the skin, disruption of regenerating fibers and interruption of parasympathetic fibers have been tried but once the syndrome is established, it becomes difficult to eliminate the symptoms. Hence, the approach has been shifted to prevention of the condition by interposition of barriers between the parotid bed and skin flap.

Interpositioning of sternocleidomastoid muscle flap (SCMMF) is one of the numerous techniques which are reported in the literature that not only prevents the gustatory sweating but also corrects the postoperative contour deformity [35]. However, the studies comparing the efficacy of SCMMF in the prevention of FS show contradictory results [59]. Hence, this meta-analysis was conducted with an aim to evaluate the effectiveness of SCMMF in the prevention of FS following parotidectomy.

Methodology

Search Strategy

An exhaustive literature search was conducted on online databases like PubMed, Medline, Cochrane, Scopus and Google Scholar in July 2019. Grey literature was also searched for any unpublished studies. Keywords like parotidectomy, Frey’s Syndrome, sternocleidomastoid muscle flap, parotid gland surgery, gustatory sweating were used for the search purpose. Boolean operators ‘AND’ and ‘OR’ were used for expanded search of relevant articles. References of the relevant articles were also explored to identify other articles.

Selection of Studies

After initial search, the title and abstracts of all the articles were reviewed. The articles dealing with operative procedures for prevention of FS following parotidectomy were selected for detailed evaluation. After detailed evaluation, studies comparing the effect of SCMMF with that of no flap on the occurrence of FS in cases of partial or total parotidectomy for benign or malignant tumor were included in the meta-analysis. The articles of English language were only recruited. Studies with incomplete data or which included patients with history of previous radiotherapy or previous surgery in parotid region were excluded. The outcome of the analysis was Frey’s Syndrome. Both the subjective as well as objective measures of the outcome were analyzed individually.

Data Extraction and Management

The data of the included studies like sample size, surgical procedures, patient characteristics, treatment group characteristics and details of outcome were extracted. For study characteristics, we included publication details (author, year of publication), study period, and location. The methodologic quality of each study was noted for assessment of risk of bias in the included studies. Risk assessment was done in seven risks of bias domains: 1. Randomization methods, 2. Allocation concealment, 3. Blinding of participants and personnel, 4. Blinding of outcome assessment, 5. Incomplete outcome data, 6. Selective reporting and 7. Other bias. Each study was independently assessed for risk of bias.

Statistical Analysis

We performed a meta-analysis for SCMMF compared to no flap in prevention of occurrence of FS. We calculated odd’s ratio with 95% confidence interval for dichotomous variables by using a random effects model in Review Manager, Version 5.3, Cochrane Collaboration. Individual analysis was done for both subjective and objective outcomes. The heterogeneity was evaluated with estimates of effect using Chi2 test and I2 statistics. We considered heterogeneity to be statistically significant if the P value was less than 0.05.

Results

Search Results

The database searches yielded 125 results. After screening of these abstracts, 101 articles were excluded and 24 full text articles were assessed for possible inclusion in the analysis. We excluded eight out of 24 full text articles due to language constraints and incomplete data and 16 articles were included in the analysis. Out of these 16 articles, 14 were included in subjective analysis and ten were included in objective analysis. (Fig. 1).

Fig. 1.

Fig. 1

Flow diagram of study selection process

Characteristics of the Included Studies

We included a total 16 studies, characteristics of which are highlighted in Table 1. Table 2 highlights the study outcomes of included studies.

Table 1.

Characteristics of included studies

S. No Author and location Age (years) Gender (M/F) Follow-up No. of cases Outcomes Methods of assessment
Cosmetic impairment Frey’s syndrossme
SCM flap No flap
1 Asal K et al. [3] Turkey 29-71 years 12/12 9–48 months 12 12 Yes Yes Objective and subjective
2 Casler and Conley [4] San francisco Not Specified Not Specified 24 months 16 104 No Yes Subjective
3 Demirci U et al. [5] Turkey 32–58 years 16/27 6 months 22 21 No Yes Subjective
4 Fee et al. [6] California Not Specified 6/18 3–60 months 15 9 Yes Yes Objective and subjective
5 Filho et al. [7] Brazil 60–67 years 22/21 12–90 months 24 19 No Yes Objective and subjective
6 Gooden EA et al. [8] Canada 56–63 years 8/18  > 12 months 13 13 Yes Yes Objective and subjective
7 Grosheva et al. [9] Germany Not Specified 74/56 6–24 months 7 51 No Yes Objective and subjective
8 Guntinas Lichius [10] Germany 14–87 years 300/310 6–26 months 391 169 Yes Yes Objective
9 Kerawala CJ et al. [11] England 26–81 years 13//23 12–60 months 21 15 Yes Yes Objective and subjective
10 Kim et al. [12] Michigan Not Specified Not Specified 12–57 months 9 10 Yes Yes Subjective
11 Kornblut et al. [13] Germany Not Specified Not Specified 12–72 months 35 35 No Yes Objective and subjective
12 Kumar J et al. [14] India 10–60 years 29/19 6 weeks-12 months 24 24 Yes Yes Subjective
13 Liang KY et al. [15] England 26–67 years 14/16 1–30 months 15 15 Yes Yes Subjective
14 Manola M et al. [16] Italy 32–77 years 49/50  < 24 months 12 20 Yes Yes Objective and subjective
15 Rustemeyer et al. [17] Germany 39–61 years Not specified 2–172 months 203 169 No Yes Subjective
16 Sood et al. [18] Nottingham 29–72 years Not specified 23–82 months 11 11 No Yes Objective and subjective

Table 2.

Outcome of selected studies

Sr. No Author Patients with SCM flap Patients with No flap
Total patients Subjective FS Objective FS Total patients Subjective FS Objective FS
1 Asal K et al. [3] 12 0 0 12 0 6
2 Casler and Conley [4] 16 2 104 49
3 Demirci U et al. [5] 22 0 21 4
4 Fee et al. [6] 15 2 3 9 4 2
5 Filho et al. [7] 24 0 0 19 9 7
6 Gooden EA et al. [8] 13 4 4 13 3 4
7 Grosheva et al. [9] 7 4 51 24
8 Guntinas Lichius [10] 391 17 169 5
9 Kerawala CJ et al. [11] 21 8 19 15 9 11
10 Kim et al. [12] 9 2 10 5
11 Kornblut AD et al. [13] 35 14 34 35 9 33
12 Kumar J et al. [14] 24 0 24 2
13 Liang KY et al. [15] 15 1 15 0
14 Manola M et al. [16] 12 + 23 0 + 2 1 + 2 20 + 15 4 + 9 7 + 11
15 Rustemeyer et al. [17] 203 49 169 37
16 Sood et al. [18] 11 0 2 11 2 9

Analysis Result

The results of this meta-analysis are represented in Figures 2 and 3. Figure 4 shows the measure of heterogeneity in the analysis, both subjective as well as objective, of the included studies. Meta-analysis of subjective outcomes of the study revealed that SCMMF flap has statistically significant less incidence of FS than that of no reconstruction. (OR = 0.36, 95% CI 0.17–0.76, p = 0.007; I2 = 61%). Meta-analysis of objective outcomes of the study revealed that there is no statistically significant difference in the occurrence of FS in both the groups. However, the results favor the use of SCMMF. (OR = 0.40, 95% CI 0.14–1.13; p = 0.08, I2 = 69%).

Fig. 2.

Fig. 2

Forest plot of subjective outcomes

Fig. 3.

Fig. 3

Forest plot of objective outcomes

Fig. 4.

Fig. 4

Funnel plots of subjective and objective meta-analysis

Risk of Bias Assessment Result

Table 3 highlights the risk of bias assessment. Most of the studies have high risk of bias which might affect the result of the analysis.

Table 3.

Assessment of risk of bias in included studies

Studies A B C D E F G
Asal K et al. Unclear Unclear Low Low Low Low Low
Casler and Conley High High Unclear Unclear Unclear Unclear Unclear
Demirci U et al. Unclear Low Low High Low Low Low
Fee et al. High Unclear Unclear Low Low Low Low
Filho et al. High Unclear Unclear Unclear Low Unclear Low
Gooden EA et al. High High Low Low Low Unclear Low
Guntinas Lichius et al. High High High High Low Unclear Low
Kerawala CJ et al. Low Unclear Low Low Low Low Low
Kim SY et al. High High Unclear Unclear Low Low Low
Kornblut AD et al. High High Unclear Unclear Low Low Low
Kumar J et al. High Unclear Unclear Unclear Low Low Low
Liang KY et al. High High Unclear Unclear Low Low Low
Manola M et al. High High Unclear Unclear Low Unclear Low
Rustemeyer J et al. High High Unclear Unclear Low Unclear Low
Sood S et al. High High Unclear High Low Low Low

A = Randomization methods

B = Allocation concealment

C = Blinding of participants and personnel

D = Blinding of outcome assessment

E = Incomplete outcome data

F = Selective reporting

G = Other bias

Discussion

Frey’s Syndrome is one of the commonest complication following parotidectomy [1921]. This syndrome is characterized by sweating, redness and warmth in preauricular region [2225]. In 1927, the pathophysiology of FS was explained to be caused due to aberrant regeneration of auriculotemporal nerve fibers which go to the parotid gland passing through the facial nerve and innervate the sweat glands and blood vessels of the skin. This leads to the pathognomonic sweating and flushing of the parotid region during eating [26]. In the earlier times, the management involved use of topical and systemic medications, along with various adjunctive procedures like extirpating the involved tissues or interrupting the neural pathways to the involved tissues [2735]. Symptoms were reduced following these modalities but they failed to achieve absolute success for long durations. Hence, to prevent FS, interpositioning some tissue between parotid bed and the skin is practiced. Various flaps used for this purpose are SCMMF, SMAS flap, temporoparietal flap, platysma, derma flaps, submandibular gland flap and vascularized dermis-fat grafts [11, 15, 3643].

The SCMMF is most commonly used flap as it is easier to rotate and obliviates the need of another incision. It not only covers all the branches of facial nerve but also provides adequate bulk to compensate for the depression caused following gland resection. Furthermore, it has high vascularity minimizing the risk of necrosis and has a low risk of complications. Despite of so many advantages, use of SCMMF following parotidectomy is controversial. Some authors recommend it [3, 7, 16, 18]; on the other hand, others disagree [911, 13, 44]. Hence, it becomes imperative to support the surgical interventions regarding their effectiveness. Other than the effectiveness of the reconstruction modality in prevention of FS, other factors such as cost, restoration of post-operative contour deformity and operating time are also important to be taken into consideration [45].

The technique of SMAS flap was developed by Owsley [46]. The SMAS layer is the deep layer of the superficial cervicofascial fascia that includes the muscles related to facial expression. The SMAS flap is used to cover the surgical defect following parotidectomy and is sutured to the perichondrium of the external ear canal and sternocleidomastoid muscle [41]. There are numerous publications focusing on the efficacy of SMAS flap in prevention of FS following parotidectomy. However, there was lack of conclusive evidence to advocate the use of SMAS flap. In 2016, meta-analysis conducted by Dulguerov N et al. concluded that the use of SMAS flap is associated with a decreased incidence of FS following parotidectomy [47].

Use of temporoparietal fascia flap (TPFF) is also mentioned in the literature for creating a barrier between the parotid bed and superficial skin [38]. Unlike temporalis flap, the TPFF is a thin flap and does not produce any fullness over zygomatic arch when rotated over it. It is based on the superficial temporal vessels. Sometimes, ligation of superficial temporal artery during parotidectomy limits the use of this flap [37]. However, there is hardly any conclusive literature to support the use of this flap as an interpositioning material.

Wang et al. [48] first evaluated the effectiveness of Platysma muscle flap (PMF) following parotidectomy. They reported PMF to be effective in reducing the incidence of FS. Similarly, Hayashi et al. [49] recommended the use of PMF following parotidectomy. However, both the articles reported that the cases in which complete coverage could not be obtained, FS persisted. The technique for use of PMF is technique sensitive as the muscle is thin, and it is supposed to be elevated along with the underlying fat as various small vessels providing vascular supply to this flap pass through the underlying fat [49].

A few reports are present in the literature which were focused on the use of derma flaps [39], submandibular gland flap [15], fascia lata [42] and posterior belly of digastric flap [50]. However, these reports are not conclusive enough for their use. Further studies comparing these flaps with commonly used flaps are recommended.

The present meta-analysis was specifically conducted to evaluated the efficacy of SMMMF in the prevention of FS following parotidectomy. Results of this analysis state that SCMMF gives a promising result but there are numerous factors that could confound results. The most important factor is the heterogeneity among the studies having different clinical and methodologic parameters. Most of the studies included are observational studies, despite the fact that RCTs are considered to be the highest level of evidence in decision-making. Inclusion of retrospective studies with a long length of follow-up also increase the chances of recall bias [51]. Another aspect is that most of the studies did not make specific inclusion criteria resulting in improper selection of the patients and affecting the end result. This bias is known as “selection bias” which is one of the most important biases affecting the study [52]. Reporting bias is another bias which is associated with reporting of age, gender and other clinical characteristics of the patients [53].

Most studies in the analysis suffer from lack of power due to small sample size [54]. This may result in a false negative conclusion. Another variable is the surgical technique with which the SCMMF is elevated and used. There is no standard technique which has been used in the studies, neither there is any mention of the dimensions of the flap to be raised. Some authors used an inferiorly based flap, whereas others used a superiorly based flap. Kim and Mathog [12] used only the superficial layer of SCMMF along with the platysma muscle and cervical fascia.

Method of detection for gustatory sweating is another confounding factor. The gold standard method to detect the objective FS is the Minor’s iodine starch test, [13, 55] but there is no standard technique and quantification of results as true or false positives. Reporting the incidence of objective FS is sometimes influenced by the existence of subjective symptoms. Length of follow-up is another factor. It has been mentioned that there is a latency period of six months for FS to develop. Hence, a lesser follow-up would underestimate the occurrence of FS. Also, longer follow-up may result in less reporting of subjective symptoms as the patient may develop tolerance in such a long time. It is also not clear if the interposition of SCMMF actually inhibits the FS or just delays it. A smaller follow-up may misconclude that SCMMF decreases the incidence of FS. Hence, it is imperative to have enough follow-up period to distinguish between the inhibition and delay of FS.

Cosmetic results were measured only in a few studies with heterogeneous methods among the studies. However, they are found to be better in flap groups. Nofal et al. [56] in their study concluded that partial thickness superiorly based SCM flap is an effective cosmetic option for reconstruction following parotidectomy.

Conclusion

The analysis suggests that SCMMF reduces the incidence of FS but considering various confounding factors, it is difficult to arrive at a conclusion. However, it is beneficial to use this flap as it also improves the cosmetic deformity. Effectiveness of SCMMF in prevention of FS can be identified by a well-constructed multi-centre RCT with proper guidelines, adequate sample size, standardized setting and proper follow-up.

Acknowledgement

None.

Funding

None.

Compliance with ethical standards

Conflict of interest

None.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Linder TE, Huber A, Schimid S. Frey syndrome after parotidectomy: a retrospective and prospective analysis. Laryngoscope. 1997;107:1496–1501. doi: 10.1097/00005537-199711000-00013. [DOI] [PubMed] [Google Scholar]
  • 2.Le FL. syndrome du nerf auriculo-temporal. Rev Neurol. 1923;2:97–104. [Google Scholar]
  • 3.Asal K, Koybasioglu A, Inal E, et al. Sternocleidomastoid muscle flap reconstruction during parotidectomy to prevent Frey’s syndrome and facial contour deformity. Ear Nose Throat J. 2005;84:173–176. [PubMed] [Google Scholar]
  • 4.Casler JD, Conley J. Sternocleidomastoid muscle transfer and superficial musculoaponeurotic system plication in the prevention of Frey’s syndrome. Laryngoscope. 1991;101:95–100. doi: 10.1288/00005537-199101000-00019. [DOI] [PubMed] [Google Scholar]
  • 5.Demirci U, Basut O, Noyan B, et al. The efficacy of sternocleidomastoid muscle flap on frey’s syndrome via a novel test: galvanic skin response. Indian J Otolaryngol Head Neck Surg. 2014;66(Suppl 1):291–298. doi: 10.1007/s12070-012-0492-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fee W, Tran L. Functional outcome after total parotidectomy reconstruction. Laryngoscope. 2004;114:223–226. doi: 10.1097/00005537-200402000-00009. [DOI] [PubMed] [Google Scholar]
  • 7.Filho WQ, Dedivitis RA, Rapoport A, Guimaraes AV. Sternocleidomastoid muscle flap preventing Frey syndrome following parotidectomy. World J Surg. 2004;28:361–364. doi: 10.1007/s00268-003-7304-1. [DOI] [PubMed] [Google Scholar]
  • 8.Gooden EA, Gullane PJ, Irish J, Katz M, Carroll C. Role of the sternocleidomastoid muscle flap preventing Frey’s syndrome and maintaining facial contour following superficial parotidectomy. J Otolaryngol. 2001;30:98–101. doi: 10.2310/7070.2001.19876. [DOI] [PubMed] [Google Scholar]
  • 9.Grosheva M, Horstmanna L, Volk GF, et al. Frey’s syndrome after superficial parotidectomy: role of the sternocleidomastoid muscle flap: a prospective nonrandomized controlled trial. Am J Surg. 2016;212(740–747):e1. doi: 10.1016/j.amjsurg.2016.01.020. [DOI] [PubMed] [Google Scholar]
  • 10.Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol. 2006;126(10):1104–1109. doi: 10.1080/00016480600672618. [DOI] [PubMed] [Google Scholar]
  • 11.Kerawala CJ, McAloney N, Stassen LF. Prospective randomised trial of the benefits of a sternocleidomastoid flap after superficial parotidectomy. Br J Oral Maxillofac Surg. 2002;40(6):468–472. doi: 10.1016/s0266-4356(02)00194-8. [DOI] [PubMed] [Google Scholar]
  • 12.Kim SY, Mathog RH. Platysma muscle-cervical fascia-sternocleidomastoid muscle (PCS) flap for parotidectomy. Head Neck. 1999;21(5):428–433. doi: 10.1002/(sici)1097-0347(199908)21:5<428::aid-hed8>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 13.Kornblut AD, Westphal P, Miehlke A. A reevaluation of the Frey syndrome following parotid surgery. Arch Otolaryngol. 1977;103(5):258–261. doi: 10.1001/archotol.1977.00780220052003. [DOI] [PubMed] [Google Scholar]
  • 14.Kumar J, Kumar S, Singh H, et al. Assessment of functional outcome after parotidectomy reconstruction. Int J Otorhinolaryngol Head Neck Surg. 2018;4(3):780–784. [Google Scholar]
  • 15.Liang KY, Breen MS, Tracy JC, Vaezi AE. Submandibular gland flap for reconstruction after parotidectomy. Laryngoscope. 2019;00:1–6. doi: 10.1002/lary.28037. [DOI] [PubMed] [Google Scholar]
  • 16.Manola M, Moscillo L, Simeon V, De Luca E. Mastella a the effectiveness of sternocleidomastoid flap versus superficial musculoaponeurotic system flap for the prevention of frey syndrome and facial depressed deformity in parotid surgery for pleomorphic adenoma. Ann Plast Surg. 2018;80(2):125–129. doi: 10.1097/SAP.0000000000001233. [DOI] [PubMed] [Google Scholar]
  • 17.Rustemeyer J, Eufinger H, Bremerich A. The incidence of Frey's syndrome. J Craniomaxillofac Surg. 2008;36(1):34–37. doi: 10.1016/j.jcms.2007.07.003. [DOI] [PubMed] [Google Scholar]
  • 18.Sood S, Quraishi MS, Jennings CR, Bradley PJ. Frey's syndrome following parotidectomy: prevention using a rotation sternocleidomastoid muscle flap. Clin Otolaryngol Allied Sci. 1999;24(4):365–368. doi: 10.1046/j.1365-2273.1999.00283.x. [DOI] [PubMed] [Google Scholar]
  • 19.Durgut O, Basut O, Demir UL, et al. Association between skin flap thickness and Frey’s syndrome in parotid surgery. Head Neck. 2013;35:1781–1786. doi: 10.1002/hed.23233. [DOI] [PubMed] [Google Scholar]
  • 20.Guntinas-lichius O, Klussmann JP, Wittekindt C, et al. Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope. 2006;116:534–540. doi: 10.1097/01.mlg.0000200741.37460.ea. [DOI] [PubMed] [Google Scholar]
  • 21.Guntinas-Lichius O, Kick C, Klussmann JP, et al. Pleomorphic ade- noma of the parotid gland: a 13-year experience of consequent man- agement by lateral or total parotidectomy. Eur Arch Otorhinolaryngol. 2004;261:143–146. doi: 10.1007/s00405-003-0632-9. [DOI] [PubMed] [Google Scholar]
  • 22.O’Neill J, Condron C, Curran A, et al. Lucja Freydhistorical rele- vance and syndrome review. Surgeon. 2008;6:178–181. doi: 10.1016/s1479-666x(08)80115-1. [DOI] [PubMed] [Google Scholar]
  • 23.Dulguerov P, Quinodoz D, Cosendai G, et al. Prevention of Frey syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg. 1999;125:833–839. doi: 10.1001/archotol.125.8.833. [DOI] [PubMed] [Google Scholar]
  • 24.Sanabria A, Kowalski L, Bradley PJ, et al. Sternocleidomastoid muscle flap in preventing Frey’s syndrome after parotidectomy: a systematic review. Head Neck. 2012;34:589–598. doi: 10.1002/hed.21722. [DOI] [PubMed] [Google Scholar]
  • 25.Gordon AB, Fiddlan RV. Frey’s syndrome after parotid surgery. Am J Surg. 1976;132:54–58. doi: 10.1016/0002-9610(76)90290-7. [DOI] [PubMed] [Google Scholar]
  • 26.Le TA. double reflexe vaso-dilatateur et sudoral de la consecutive aux blessures de la loge parotidienne. Rev Neurol (Paris) 1927;1:447–460. [Google Scholar]
  • 27.Laage-Hellman J-E. Treatment of gustatory sweating and flushing. Acta Otolaryngol. 1958;49:132–143. doi: 10.3109/00016485809134736. [DOI] [PubMed] [Google Scholar]
  • 28.Glaister DH, Hearnshaw JR, Heffron PF, et al. The mechanism of post-parotidectomy gustatory sweating (the auriculotemporal syndrome) Br Med J. 1958;2:942–946. doi: 10.1136/bmj.2.5102.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Langenskoid A. Gustatory local hyperhidrosis following injuries in the parotid region. Acta Chir Scand. 1946;93:294–306. [PubMed] [Google Scholar]
  • 30.Shelley WB, Horvath PN. Comparative study on the effect of anticholinergic compounds on sweating. J invest Dermatol. 1951;16:267–274. doi: 10.1038/jid.1951.34. [DOI] [PubMed] [Google Scholar]
  • 31.Gardner WJ, McCubbin JW. Auriculotemporal Syndrome: Gustatory Sweating due to misdirection of regenerated nerve fibers. JAMA. 1956;160:272–277. doi: 10.1001/jama.1956.02960390022007. [DOI] [PubMed] [Google Scholar]
  • 32.Needles W. The auriculotemporal syndrome: with a suggestion regarding therapy. Arch Neurol Psychiatry. 1936;35:357–360. [Google Scholar]
  • 33.Coldwater KB. Surgical treatment of the auriculotemporal syndrome. Arch Surg. 1954;69:54–57. doi: 10.1001/archsurg.1954.01270010056008. [DOI] [PubMed] [Google Scholar]
  • 34.Golding-Wood PH. Tympanic neurectomy. J Laryngol. 1962;76:683–693. doi: 10.1017/s0022215100059909. [DOI] [PubMed] [Google Scholar]
  • 35.Smith RO, Hemenway WG, Stevens KM, et al. Jacobson’s Neurectomy for Frey’s syndrome. Am J Surg. 1970;120:478–481. doi: 10.1016/s0002-9610(70)80010-1. [DOI] [PubMed] [Google Scholar]
  • 36.Bugis SP, Young JEM, Archibald SD. Sternocleidomastoid flap following parotidectomy. Head Neck. 1990;12:430–435. doi: 10.1002/hed.2880120511. [DOI] [PubMed] [Google Scholar]
  • 37.Rubinstein RY, Rosen A, Leeman D. Frey syndrome treatment with temporoparietal fascia flap interposition. Arch Otolaryngol Head Neck Surg. 1999;125:808–811. doi: 10.1001/archotol.125.7.808. [DOI] [PubMed] [Google Scholar]
  • 38.Cesteleyn L, Helman J, King S, Van de Vyvere G. Temporoparietal fascia flaps and superficial musculoaponeurotic system plication in parotid surgery reduces Frey’s syndrome. J Oral Maxillofac Surg. 2002;60:1284–1298. doi: 10.1053/joms.2002.35725. [DOI] [PubMed] [Google Scholar]
  • 39.Harada T, Inoue T, Harashina T, Hatoko M, Ueda K. Dermis-fat graft after parotidectomy to prevent Frey’s syndrome and the concave deformity. Ann Plast Surg. 1993;31:450–452. doi: 10.1097/00000637-199311000-00012. [DOI] [PubMed] [Google Scholar]
  • 40.Sinha UK, Saadat D, Doherty CM, Rice DH. Use of AlloDerm implant to prevent Frey syndrome after parotidectomy. Arch Facial Plast Surg. 2003;5:109–112. doi: 10.1001/archfaci.5.1.109. [DOI] [PubMed] [Google Scholar]
  • 41.Barberá R, Castillo F, D'Oleo C, Benítez S, Cobeta I. Superficial musculoaponeurotic system flap in partial parotidectomy and clinical and subclinical Frey's syndrome. Cosmesis and quality of life. Head Neck. 2014;36:130–6. doi: 10.1002/hed.23215. [DOI] [PubMed] [Google Scholar]
  • 42.Wallis KA, Gibson T. Gustatory sweating following parotidectomy. Correction by a fascia lata graft. Br J Plast Surg. 1978;31:68–71. doi: 10.1016/0007-1226(78)90020-6. [DOI] [PubMed] [Google Scholar]
  • 43.Allen RJ, Kaplan J. Reconstruction of a parotidectomy defect using a paraumbilical perforator flap without deep inferior epigastric vessels. J Reconstr Microsurg. 2000;16:255–257. doi: 10.1055/s-2000-7330. [DOI] [PubMed] [Google Scholar]
  • 44.Kornblut AD. The fallacy of preventing Frey syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg. 2000;126:556–557. doi: 10.1001/archotol.126.4.556. [DOI] [PubMed] [Google Scholar]
  • 45.Lipscomb J, Donaldson MS, Hiatt RA. Cancer outcomes research and the arenas of application. J Natl Cancer Inst Monogr. 2004;2004:1–7. doi: 10.1093/jncimonographs/lgh038. [DOI] [PubMed] [Google Scholar]
  • 46.Owsley JQ., Jr SMAS-platysma facelift A bidirectional cervicofacial rhytidectomy. Clin Plast Surg. 1983;10:429–440. [PubMed] [Google Scholar]
  • 47.Dulguerov N, Makni A, Dulguerov P. The superficial musculoaponeurotic system flap in the prevention of frey syndrome: a meta-analysis. Laryngoscope. 2016;126:1581–1584. doi: 10.1002/lary.25895. [DOI] [PubMed] [Google Scholar]
  • 48.Wang WH, Zhu J, Li M, Xia B, Xu B. Usefulness of platysma muscle flap following superficial parotidectomy. J Craniomaxillofac Surg. 2013;41(1):10–14. doi: 10.1016/j.jcms.2012.05.002. [DOI] [PubMed] [Google Scholar]
  • 49.Hayashi A, Mochizuki M, Suda S, Natori Y, Ando E, Yoshizawa H, Senda D, Tanaka R, Mizuno H. Effectiveness of platysma muscle flap in preventing Frey syndrome and depressive deformities after parotidectomy. J Plast Reconstr Aesthet Surg. 2016;69(5):663–672. doi: 10.1016/j.bjps.2015.12.021. [DOI] [PubMed] [Google Scholar]
  • 50.Rai A, Jain A, Khan M. Posterior belly of digastric muscle flap for contour deformity correction after superficial parotidectomy. J Stomatol Oral Maxillofac Surg. 2018;119(4):304–306. doi: 10.1016/j.jormas.2017.10.013. [DOI] [PubMed] [Google Scholar]
  • 51.Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43:87–91. doi: 10.1016/0895-4356(90)90060-3. [DOI] [PubMed] [Google Scholar]
  • 52.Longford NT. Selection bias and treatment heterogeneity in clinical trials. Stat Med. 1999;18:1467–1474. doi: 10.1002/(sici)1097-0258(19990630)18:12<1467::aid-sim149>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  • 53.McGauran N, Wieseler B, Kreis J, Schuler Y-B, Kolsch H, Kaiser T. Reporting bias in medical research—a narrative review. Trials. 2010;11:1–37. doi: 10.1186/1745-6215-11-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Murray WB, Gouws E. ‘‘No difference v. not enough evidence"—calculating the power and beta error. S Afr Med J. 1993;83:863–865. [PubMed] [Google Scholar]
  • 55.Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweißabsonderung. Dt Z Nervenheilk. 1928;101:302–309. [Google Scholar]
  • 56.Nofal AA, Mohamed M. Sternocleido mastoid Muscle Flap after Parotidectomy. Int Arch Otorhino-laryngol. 2015;19(4):319–324. doi: 10.1055/s-0035-1549155. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Maxillofacial & Oral Surgery are provided here courtesy of Springer

RESOURCES